Amplify Seymour Cannabis ETFCNBS
CNBS
0
Funds holding %
of 7,139 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3.57% more ownership
Funds ownership: 11.27% [Q3] → 14.84% (+3.57%) [Q4]
0% more funds holding
Funds holding: 28 [Q3] → 28 (+0) [Q4]
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
40% less capital invested
Capital invested by funds: $3.17M [Q3] → $1.91M (-$1.26M) [Q4]
58% less call options, than puts
Call options by funds: $23K | Put options by funds: $55K
Research analyst outlook
We haven’t received any recent analyst ratings for CNBS.
Financial journalist opinion
Based on 3 articles about CNBS published over the past 30 days
Positive
Seeking Alpha
1 week ago
CNBS Is A New Opportunity For Cannabis Investors
Amplify's CNBS ETF has shifted focus to American cannabis and hemp, making it a better option than MSOS due to its more diversified structure. CNBS's portfolio is less concentrated in a few stocks compared to MSOS, reducing risk and offering better potential for long-term performance. Risks include 280E taxation remaining, CNBS's smaller size, and limited liquidity, but Tim Seymour's active management is a positive factor.
Positive
Market Watch
2 weeks ago
Cannabis stocks climb on RFK Jr. approval, Senate marijuana-banking hearing
Cannabis stocks tend to move on speculation around potential federal reforms around pot.
Neutral
GlobeNewsWire
3 weeks ago
Amplify ETFs Aligns Global and U.S. Cannabis Exposure Across MJ and CNBS
CHICAGO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Amplify ETFs announces the realignment of its cannabis ETFs to provide investors with dynamic exposure to the cannabis industry. On January 28, 2025, the Amplify Seymour Cannabis ETF (CNBS) will change its investment policy to invest in securities of U.S. companies engaged in cannabis and hemp-related activities.
Positive
ETF Trends
7 months ago
Disruptive Theme of the Week: The Rise of Active Thematic ETFs
This year has been a big year for active ETFs! According to Morningstar, even though actively managed ETFs still only represent 7% of ETF assets, they accounted for 25% of the flows in the first half of this year, growing to a record $889 billion from their start of the year, $714 billion.
Positive
Seeking Alpha
7 months ago
Cannabis Investing In The Age Of Legalization With Julian Lin, Tim Seymour And Pablo Zuanic
How to best invest in the cannabis sector with Pablo Zuanic, Tim Seymour and Julian Lin. Compelling metrics for evaluating cannabis stocks include EV/EBITDA, EV/sales, and total addressable market.
Positive
Zacks Investment Research
9 months ago
Best ETF Areas of Last Week
Wall Street was upbeat last week. The Fed's plan to slower the balance sheet tightening process and the release of downbeat jobs data dragged down bond yields.
Positive
Seeking Alpha
9 months ago
Mario Naric On Canada's Shakeout Phase
The Canadian cannabis industry is in a shakeout phase, with poorly run businesses struggling and the industry maturing.
Positive
ETF Trends
10 months ago
ETF Themes That Dominated in Q1 2023
As the first quarter comes to a close, clearly, there have been some thematic winners in terms of flows and investment performance. Artificial Intelligence AI-themed ETFs remain among the top recipients of investor flows this year.
Positive
Zacks Investment Research
11 months ago
Is Rescheduling a Certainty for Cannabis? ETFs That Surge
In a White House meeting, Vice President Kamala Harris this week urged the DEA to expedite the rescheduling of marijuana, criticizing its current Schedule 1 classification as "absurd" and "patently unfair." She put stress on the need for swift action and highlighted ongoing efforts toward rescheduling.
Positive
Zacks Investment Research
11 months ago
Cannabis ETFs Jump on Imminent Rescheduling News
Cannabis stocks & ETFs jumped on Mar 15 after a prominent hedge fund manager suggested that regulators will soon reclassify marijuana as a less dangerous drug.
Charts implemented using Lightweight Charts™